BAWEI
837023
Yili Chuanning Biotechnology
301301
Shanghai Menon Animal Nutrition Technology
301156
4
Tongling Jieya Biologic Technology
301108
5
XI'AN WONDER
836419
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 1,250.00%56.03M | -53.26%4.28M | -53.26%4.28M | -50.36%2.53M | -17.52%6.4M | -61.32%4.15M | 7.95%9.16M | 7.95%9.16M | -43.86%5.09M | -4.44%7.76M |
-Cash and cash equivalents | 1,250.00%56.03M | -53.26%4.28M | -53.26%4.28M | -50.36%2.53M | -17.52%6.4M | -61.32%4.15M | 7.95%9.16M | 7.95%9.16M | -43.86%5.09M | -4.44%7.76M |
Receivables | 0.30%187.49M | -11.54%187.76M | -11.54%187.76M | -2.61%144.19M | 1.58%149.5M | -14.55%186.93M | -13.35%212.26M | -13.35%212.26M | -0.74%148.04M | 0.78%147.17M |
-Accounts receivable | 0.30%187.49M | -11.54%187.76M | -11.54%187.76M | -2.61%144.19M | 1.58%149.5M | -14.55%186.93M | -13.35%212.26M | -13.35%212.26M | -0.74%148.04M | 0.78%147.17M |
Inventory | 15.18%119.61M | 7.33%122.94M | 7.33%122.94M | 2.09%121.57M | 6.86%114.96M | 12.21%103.84M | 6.69%114.54M | 6.69%114.54M | -7.87%119.08M | 8.64%107.58M |
Restricted cash | 48.11%24.04M | 54.37%24.73M | 54.37%24.73M | 53.27%25.37M | 51.51%24.64M | -0.86%16.23M | 14.66%16.02M | 14.66%16.02M | -15.81%16.55M | -9.46%16.26M |
Other current assets | -0.02%85.67M | 42.60%78.47M | 42.60%78.47M | 7.45%74.77M | -12.60%68.55M | -22.07%85.68M | -66.46%55.02M | -66.46%55.02M | -58.00%69.59M | -40.66%78.44M |
Total current assets | 19.15%472.83M | 2.75%418.19M | 2.75%418.19M | 2.81%368.42M | 1.91%364.05M | -11.49%396.84M | -24.46%407.01M | -24.46%407.01M | -24.21%358.35M | -11.44%357.21M |
Non current assets | ||||||||||
Net PPE | 5.62%6.43B | 5.94%6.4B | 5.94%6.4B | 6.28%6.3B | 6.73%6.19B | 6.73%6.09B | 6.76%6.04B | 6.76%6.04B | 7.20%5.93B | 7.22%5.8B |
-Gross PPE | ---- | 5.76%8.78B | 5.76%8.78B | ---- | ---- | ---- | 5.81%8.3B | 5.81%8.3B | ---- | ---- |
-Accumulated depreciation | ---- | -5.30%-2.38B | -5.30%-2.38B | ---- | ---- | ---- | -3.37%-2.26B | -3.37%-2.26B | ---- | ---- |
Goodwill and other intangible assets | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M |
-Goodwill | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M | 0.00%357.59M |
Other non current assets | 37.22%67.63M | 12.90%59.06M | 12.90%59.06M | 14.22%57.12M | -1.37%50.1M | 2.76%49.29M | 10.55%52.31M | 10.55%52.31M | 3.21%50.01M | 0.67%50.8M |
Total non current assets | 5.42%7.63B | 5.36%7.58B | 5.36%7.58B | 5.86%7.49B | 5.95%7.35B | 5.91%7.24B | 6.12%7.19B | 6.12%7.19B | 6.47%7.07B | 6.45%6.94B |
Total assets | 6.13%8.1B | 5.22%8B | 5.22%8B | 5.71%7.85B | 5.75%7.71B | 4.84%7.63B | 3.87%7.6B | 3.87%7.6B | 4.43%7.43B | 5.40%7.29B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -8.38%88.45M | -4.95%193.51M | -4.95%193.51M | -21.43%93.75M | -3.48%91.26M | -7.84%96.54M | -31.59%203.59M | -31.59%203.59M | -19.63%119.32M | -21.98%94.55M |
-accounts payable | -8.38%88.45M | -10.09%111.79M | -10.09%111.79M | -21.43%93.75M | -3.48%91.26M | -7.84%96.54M | -38.29%124.34M | -38.29%124.34M | -19.63%119.32M | -21.98%94.55M |
-Total tax payable | ---- | 3.11%81.72M | 3.11%81.72M | ---- | ---- | ---- | -17.53%79.25M | -17.53%79.25M | ---- | ---- |
Current accrued expenses | -6.27%279.6M | 9.31%106.56M | 9.31%106.56M | -9.27%286.07M | -1.33%244M | -3.34%298.3M | 15.72%97.49M | 15.72%97.49M | 4.85%315.29M | 1.67%247.29M |
Current debt and capital lease obligation | 7.74%3.66M | 290.70%403.55M | 290.70%403.55M | 291.03%403.45M | 218.63%328.39M | -98.63%3.4M | -30.03%103.29M | -30.03%103.29M | -30.05%103.18M | 3,356.17%103.06M |
-Current debt | ---- | 300.15%399.95M | 300.15%399.95M | 300.32%399.92M | 225.41%324.93M | ---- | -30.84%99.95M | -30.84%99.95M | -30.85%99.9M | --99.85M |
-Current capital lease obligation | 7.74%3.66M | 7.73%3.6M | 7.73%3.6M | 7.76%3.53M | 7.75%3.46M | 7.77%3.4M | 7.75%3.34M | 7.75%3.34M | 7.73%3.28M | 7.75%3.21M |
Current deferred liabilities | ---- | -40.21%16.54M | -40.21%16.54M | ---- | ---- | ---- | 5.81%27.66M | 5.81%27.66M | ---- | ---- |
Other current liabilities | -44.17%25.93M | -47.20%32.26M | -47.20%32.26M | -5.46%30M | 27.14%36.16M | 134.93%46.44M | 188.97%61.1M | 188.97%61.1M | 45.69%31.73M | 55.64%28.44M |
Current liabilities | -10.58%397.64M | 49.97%802.2M | 49.97%802.2M | 42.80%813.27M | 47.84%699.81M | -34.67%444.68M | -13.84%534.9M | -13.84%534.9M | -7.91%569.51M | 22.73%473.35M |
Non current liabilities | ||||||||||
Long term provisions | ---- | -3.83%58.08M | -3.83%58.08M | ---- | ---- | ---- | -2.22%60.39M | -2.22%60.39M | ---- | ---- |
Long term debt and capital lease obligation | 12.98%3.13B | 0.26%2.7B | 0.26%2.7B | 0.78%2.57B | 0.31%2.57B | 18.02%2.77B | 8.33%2.69B | 8.33%2.69B | 5.47%2.55B | 1.38%2.57B |
-Long term debt | 13.14%3.13B | 0.40%2.7B | 0.40%2.7B | 0.92%2.57B | 0.44%2.57B | 18.22%2.77B | 8.50%2.68B | 8.50%2.68B | 5.63%2.54B | 1.52%2.56B |
-Long term capital lease obligation | -79.72%932K | -65.85%1.87M | -65.85%1.87M | -55.78%2.8M | -48.14%3.73M | -42.52%4.6M | -37.94%5.46M | -37.94%5.46M | -34.11%6.33M | -30.89%7.19M |
Non current deferred liabilities | 12.19%695.3M | 11.11%786.68M | 11.11%786.68M | 16.12%640.08M | 15.24%629.31M | 14.49%619.74M | 11.60%707.99M | 11.60%707.99M | 6.40%551.22M | 5.30%546.07M |
Employee benefits | ---- | -24.83%56.6M | -24.83%56.6M | ---- | ---- | ---- | -11.13%75.3M | -11.13%75.3M | ---- | ---- |
Other non current liabilities | -4.47%317.61M | -12.43%78.12M | -12.43%78.12M | 0.72%348.17M | -3.19%345.3M | -7.19%332.45M | -21.42%89.21M | -21.42%89.21M | -5.37%345.67M | -4.17%356.66M |
Total non current liabilities | 9.87%4.81B | 1.34%4.34B | 1.34%4.34B | 2.54%4.22B | 1.76%4.21B | 11.99%4.38B | 6.17%4.28B | 6.17%4.28B | 4.07%4.12B | 1.57%4.13B |
Total liabilities | 7.98%5.21B | 6.74%5.14B | 6.74%5.14B | 7.43%5.04B | 6.49%4.91B | 5.07%4.82B | 3.50%4.82B | 3.50%4.82B | 2.45%4.69B | 3.41%4.61B |
Shareholders'equity | ||||||||||
Share capital | 0.15%649K | 0.00%648K | 0.00%648K | 0.00%648K | 2.05%648K | 2.37%648K | 2.37%648K | 2.37%648K | 5.71%648K | 6.37%635K |
-common stock | 0.15%649K | 0.00%648K | 0.00%648K | 0.00%648K | 2.05%648K | 2.37%648K | 2.37%648K | 2.37%648K | 5.71%648K | 6.37%635K |
Retained earnings | 9.16%913.65M | 8.07%877.02M | 8.07%877.02M | 8.96%836.13M | 6.69%828.96M | 5.16%836.95M | 5.20%811.5M | 5.20%811.5M | 3.45%767.36M | 3.66%776.98M |
Paid-in capital | 0.27%2.09B | 0.26%2.08B | 0.26%2.08B | 0.29%2.08B | 3.35%2.08B | 3.90%2.08B | 3.97%2.08B | 3.97%2.08B | 9.34%2.08B | 10.70%2.02B |
Less: Treasury stock | -0.06%97.94M | -0.54%97.39M | -0.54%97.39M | -0.58%97.56M | -0.54%97.78M | -0.49%97.99M | -0.47%97.93M | -0.47%97.93M | -0.46%98.12M | -0.47%98.3M |
Gains losses not affecting retained earnings | 12.65%-6.59M | 12.43%-6.7M | 12.43%-6.7M | 8.76%-7.32M | 6.62%-7.43M | 4.55%-7.54M | 2.45%-7.66M | 2.45%-7.66M | -7.66%-8.02M | -7.54%-7.96M |
Total stockholders'equity | 2.96%2.9B | 2.60%2.86B | 2.60%2.86B | 2.78%2.82B | 4.49%2.81B | 4.46%2.81B | 4.51%2.79B | 4.51%2.79B | 8.00%2.74B | 9.02%2.69B |
Total equity | 2.96%2.9B | 2.60%2.86B | 2.60%2.86B | 2.78%2.82B | 4.49%2.81B | 4.46%2.81B | 4.51%2.79B | 4.51%2.79B | 8.00%2.74B | 9.02%2.69B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |